A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring

Summary

The proposed study is a single-center, double-blind, randomised, placebo-controlled trial to evaluate the delivery of dapivirine from matrix vaginal rings over a 56 and 57 day period and to assess the safety as compared to placebo vaginal rings in 48 healthy, HIV-negative, sexually active women.

Timeline

Start

2010-04

Primary completion

2010-09

Completion

2010-09

Drugs

Indications